Rush Presbyterian St. Lukes — Chicago, Illinois

Rush Presbyterian St. Lukes is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Rush Presbyterian St. Lukes has participated in 2 clinical trials.

Therapeutic areas: Hemophilia A With Inhibitors, Hemophilia A.

Sponsors: New York Presbyterian Hospital, Baxalta now part of Shire.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Presbyterian St. Lukes?

Rush Presbyterian St. Lukes has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Presbyterian St. Lukes conducted?

Rush Presbyterian St. Lukes has 2 clinical trials on record. Their work covers Hemophilia A With Inhibitors, Hemophilia A.

Is Rush Presbyterian St. Lukes accredited by Crixeo Health?

Rush Presbyterian St. Lukes has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush Presbyterian St. Lukes?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.